Table 1.
CAF marker | Bio function in tumor microenvironment | Expressing cell | Ref. |
α-SMA | Promoting tumorigenesis, ECM remodeling, proliferation, drug resistance, immune tolerance through T and NK, DC cells exhaustion, Th2 responses, M2 and Treg recruitment | Vascular, muscular cells pericytes, fibroblasts | [25-27] |
FAP | Promoting tumorigenesis, tumor invasion, ECM remodeling, immune tolerance, Th2 responses, M2 and Treg recruitment | Rarely expressed in normal tissues, epithelial tumor cells, M2 macrophages, tumor cells, tumor-promoting mesenchymal stromal cells, fibroblastic stromal cells | [27-30] |
FSP1 | ECM remodeling, tumor development, metastasis through VEGF-A and TNC-C, immune tolerance through M2 polarization recruitment | Fibroblasts, epithelial and endothelial cells | [31] |
PDPN | tumor development, immune tolerance through T cell anergy, M2 polarization, and Treg recruitment | Endothelial cells | [32,33] |
Collagen | ECM remodeling, angiogenesis, metastasis, immune suppression through M2 recruitment | Fibroblasts, tumor cells, endothelial cells | [34-36] |
Vimentin | EMT mediated metastasis, tumorigenesis, and tumor development | Fibroblasts, mesenchymal cells | [37,38] |
ITGA11 | EMT, tumor progression | Mesenchymal cells | [39-41] |
PDGFRα/β | Tumor development, immune evasion via T cell exhaustion and M2 polarization, angiogenesis | Fibroblasts, vascular smooth muscle cells, pericytes | [42,43] |
CD10/GPR77 | Inflammatory signaling, supporting CSC survival, promoting tumorigenesis, chemoresistance | Bone marrow mesenchymal stem cells, pre-B lymphocytes | [44,45] |
TNC | ECM remodeling, EMT-mediated metastasis, angiogenesis and immunomodulation, tumor development | Fibroblasts, tumor cells, endothelial cells | [46-48] |
Periostin | Tumor proliferation, metastasis | Fibroblasts, tumor cells, mesenchymal stem cells | [49,50] |
Caveolin-1 | ECM remodeling and desmoplastic reaction, cancer cell migration, and invasion | Adipocytes, endothelial cells, epithelial cells, pneumocytes, and fibroblasts | [51,52] |
CAF: Cancer-associated fibroblast; α-SMA: alpha-smooth muscle actin; ECM: extracellular matrix; NK: natural killer; DC: dendritic cell; Th: T helper; M2: macrophage; Treg: T regulatory; FAP: fibroblast activating protein; FSP: fibroblast-specific protein; VEGF: vascular endothelial growth factor; TNC: tenascin; PDPN: podoplanin; EMT: epithelial-mesenchymal transition; ITGA11: α11β1 integrin; PDGFRα/β: platelet-derived growth factor receptor α/β; GPR: G-protein coupled receptor; CSC: cancer stem cell.